|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Patento numeris | 2594285 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12187298.0 |
| Europos patento paraiškos padavimo data | 2007-04-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 793997 P | 2006-04-21 | US | |
| 788697 | 2007-04-19 | US |
| (72) |
Callahan, William J., US
Remmele, Richard L., Jr., US
Latypov, Ramil F., US
Liu, Dingjiang, US
Ratnaswamy, Gayathri, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | Lyophilized therapeutic peptibody formulations |
| Lyophilized therapeutic peptibody formulations |